Briefly summarized, embodiments of the present invention are directed to a catheter assembly used to gain access to a vasculature or other internal portion of a patient. The catheter assembly includes a catheter tube that defines one or more lumens, with at least one lumen optionally capable of power injection, in one embodiment. A proximal portion of the catheter tube is sized and configured so as to reside within a portion of the vessel that is disposed relatively close to the insertion site of the catheter tube into the patient. In particular, as such portions of the vessel are of relatively small diameter, the proximal portion of the catheter tube is similarly of relatively small diameter and of relatively low stiffness so as to prevent substantial occlusion of the vessel by the catheter tube and lessen vessel damage.
Moreover, a distal portion of the catheter tube is sized and configured such that the distal portion remains stable within the vessel during infusion of fluids therethrough. Particularly, the distal portion of the catheter tube is configured to avoid whipping of the distal tip within the vessel during fluid infusion so as to prevent vessel damage. This stability of the catheter tube's distal portion is especially helpful during power injection of fluids into the vessel.
In one embodiment, stability of the distal tip of the catheter tube is accomplished by flaring, or increasing the cross sectional size of the distal portion of the tube, thus increasing the areal size of the one or more catheter lumens and improving the area moment of inertia of the distal portion. In another embodiment, the elastic modulus, or stiffness, of the distal portion can be increased relative to the proximal portion of the catheter tube. In another embodiment, both the area moment of inertia and the modulus can be modified to enhance distal portion stability. Note that these and related parameters can be modified in other ways as well.
Thus, in one embodiment, a catheter tube for insertion into a body of a patient is disclosed. The catheter tube includes a distal portion that remains stable during fluid infusion into the patient, thus reducing or eliminating whipping of the catheter distal tip, even during power injection. In one embodiment, the catheter tube defines at least one lumen and is formed from a tube material that defines a proximal portion and a distal portion of the catheter tube. The catheter tube is configured such that the arithmetic product of an elastic modulus and an area moment of inertia for at least a portion of the distal portion of the catheter tube defined by the catheter tube material is greater relative the arithmetic product of an elastic modulus and an area moment of inertia for at least a portion of the proximal portion of the catheter tube.
In another embodiment, an implantable vascular access port system is disclosed, wherein a stabilized catheter tube similar to that described above is operably connected to an implantable access port, such as an arm port, for instance. These and other uses of the stabilized catheter tube, such as its use as a PICC or other catheter assembly for providing external access to a patient's vasculature, are contemplated.
These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of embodiments of the invention as set forth hereinafter.
A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention, and are neither limiting nor necessarily drawn to scale.
For clarity it is to be understood that the word “proximal” refers to a direction relatively closer to a clinician using the device to be described herein, while the word “distal” refers to a direction relatively further from the clinician. For example, the end of a catheter placed within the body of a patient is considered a distal end of the catheter, while the catheter end remaining outside the body is a proximal end of the catheter. Also, the words “including,” “has,” and “having,” as used herein, including the claims, shall have the same meaning as the word “comprising.”
Embodiments of the present invention are generally directed to a catheter assembly used to gain access to a vasculature or other internal portion of a patient. The catheter assembly includes a catheter tube that defines one or more lumens, with at least one lumen capable of power injection, in one embodiment. A proximal portion of the catheter tube is sized and configured so as to reside within a portion of the vessel that is disposed relatively close to the insertion site of the catheter tube into the patient. In particular, as such portions of the vessel are of relatively small diameter, the proximal portion of the catheter tube is similarly of relatively small diameter and of relatively low stiffness so as to enable ease of passage of the catheter tube through the vessel and to prevent substantial occlusion of the vessel by the catheter tube
Moreover, a distal portion of the catheter tube is sized and configured such that it remains stable within the vessel during infusion of fluids therethrough. Particularly, the distal portion of the catheter tube is configured to avoid whipping of the distal tip within the vessel during fluid infusion so as to prevent vessel damage. This stability of the catheter tube's distal portion is especially helpful during power injection of fluids into the vessel.
In one embodiment, stability of the distal tip of the catheter tube is accomplished by flaring, or increasing the cross sectional size of the distal portion of the tube thus increasing the areal size of the one or more catheter lumens and improving the moment area of inertia of the distal portion. In another embodiment, the elastic modulus, or stiffness, of the distal portion can be increased relative to the proximal portion of the catheter tube. In another embodiment, both the moment area of inertia and the modulus can be modified to enhance distal portion stability. Note that these and related parameters can be modified in other ways as well and that additional configurations for increasing distal tip stability are disclosed. In addition to the catheter tubes described herein as part of catheter assemblies, the principles to be disclosed can be employed with other tubular medical devices as well.
Reference is first made to
The proximal tapered region 24 provides sufficient outer wall thickness and rigidity for the catheter tube 12 of the present embodiment so as to prevent kinking and to enable the tube to be adjusted with respect to an insertion site in the skin of the patient during insertion and adjustment of the catheter 10. Furthermore, the proximal tapered region 24 serves to plug the insertion site through which the catheter tube passes into the patient's body, thus reducing bleeding or other complications at the site.
The remainder of the proximal portion 20 of the catheter tube 12 resides within distal portions of the vessel that are typically located relatively close to the catheter insertion site in extremities of the patient, such as the arm. Such outlying, or distal, vessels are relatively smaller than the larger vessels located deeper within the body in which the distal portion 30 of the catheter tube 12 is disposed. Thus, the proximal portion 20 of the catheter tube 12 distal to the tapered region 24 is similarly sized relatively small so that this portion can reside in the relatively small vessel without occluding a significant portion thereof, which in turn reduces the risk of thrombus. Further, the smaller size of the proximal portion 20 enables it to bend more easily during insertion into the vessel along a potentially tortuous path, resulting in less trauma and damage to the vessel.
As best seen in
In greater detail, it is appreciated that an unsupported stable length, L, of a distal portion of a catheter tube can be characterized by:
where ρ is the density of the injected fluid, Q is the flow rate of the injected fluid, A is the cross sectional lumen area of the catheter tube, E is the elastic modulus of the catheter tube material from which the outer wall 13 and septum 15 are formed, I is the area moment of inertia of the outer wall and septum material, and c is a constant of proportionality.
From equation (1), it is seen that the stability length L of the catheter tube 12 can be increased by increasing one or more of the parameters E, I, and A. The increased size of the distal portion 30 of the catheter tube 12 and the portions of the lumens 14 it defines (
As discussed above, an increase in the size of the distal portion 30 and/or other portions of the catheter tube 12 increases the area moment of inertia I and thus improves tip stability. Note that I is directly related by the fourth power of the radius of the catheter tube. As such, a relatively small increase in the cross sectional size of the catheter tube can have a significant effect on I, which enhances distal tip stability. Further note that I can be beneficially improved by increasing the thickness of the outer wall and/or septum of the catheter tube while not increasing the area A of the lumen(s) of the tube.
Also, the flexural stiffness, defined as the product of the parameters E and I, is higher in the distal portion 30 relative that of the proximal portion 20, in one embodiment, in order to provide distal tip stability during fluid infusion. This can be accomplished by increasing the elastic modulus and/or the area moment of inertia for the distal portion over that of the proximal portion in any one of the ways discussed herein, or in other ways contemplated by one skilled in the art.
Again as discussed above, an increase in the size of the distal portion 30 and/or other portions of the catheter tube 12 increases the area A of the lumens 14 and thus improves tip stability. Note that in other embodiments lumen area A can be desirably increased in other ways as well, including: a thinning of the outer wall and septum while taking care not to reduce the area moment of inertia A of the distal portion; increasing the lumen area while maintaining the outer diameter of the catheter tube constant, etc.
Though it can be formed to a variety of lengths to suit different uses and applications, in one embodiment the proximal taper region 24 of the proximal portion 20 is about 4 cm in length, the remainder of the proximal portion is about 20 to about 25 cm, the distal taper region 34 of the distal portion 30 is about 4 cm, and the remainder of the distal portion is about 35 cm. Of course, other lengths for the various segments described above can be employed.
Moreover, the lengths, cross sectional sizes of, and relative size differences between the various segments can also vary from what is shown and described herein, as appreciated by one skilled in the art. In the present embodiment, the approximate diameter, wall thickness, and septum thickness (in inches) for each of the cross section views shown in
In this and various other embodiments described herein the catheter tube 12 is extruded or otherwise formed from one or more of a variety of suitable materials, including thermoplastic polyurethanes sold under the trademarks TECOFLEX (type 93AB30) and TECOTHANE (type 95A) of Lubrizol Advanced Materials, Inc., and CARBOTHANE (type 95A), the thermoplastic elastomer sold under the trademark PEBAX of Arkema, Inc., silicone, polyesters, polyethylene, etc. Other suitable materials may also be acceptably used, as appreciated by one skilled in the art.
Note that, though the distal portion of the catheters described here are trimmable, it is desirable that the length of the distal portion remaining after trimming is at least as long as the unsupported stable length L as determined by equation (1), above. In one embodiment, this length is from about 3 to about 10 cm, though other stable lengths are possible, per equation (1).
In
With reference to
It is further appreciated that other catheter factors can be adjusted to maximize distal tip stability for the catheter tube 12, including the length of the flared distal portion alone and as a function of overall catheter tube length, the density of the catheter tube material, the degree of flare of the distal portion with respect to non-flared tube portions, the interaction of modulus, area moment of inertia, and lumen area in the flared portion, etc.
In one embodiment, both the proximal and distal portions are formed of a similar material, with the distal portion being treated to be stiffer relative the proximal portion. Examples of such treatment of the distal portion include irradiation, application of a solvent or activator, heat treatment, etc. In another embodiment, it is the proximal portion that is treated to exhibit a less-stiff elastic modulus.
In one possible embodiment, the entire length of the catheter tube can be treated so as to exhibit a relatively stiff modulus. In another embodiment, the catheter tube can be extruded from two different materials to provide a soft proximal portion and a relatively stiffer distal portion. In yet another embodiment, a soft proximal tube portion can be formed then joined via adhesion to a pre-formed, relatively stiffer distal portion. These and other variations are therefore contemplated.
In contrast, trimming the catheter tube 12 at the location indicated at 11B-11B in
So configured, the distal portion 30 of the catheter tube 12 initially defines a similar outer diameter as that of the more proximal tube portion (
In
Note that though the distal portions of the catheter tubes described above include both increased outer wall thickness and increased lumen area relative to the more proximal portions of the catheter tubes, in other embodiments the outer wall thickness can vary independently of lumen area in the distal portion, and vice versa. Further, the length and relative size of the distal, proximal, and portions of the catheter tube can also vary from what is shown and described herein. Note also that various single and dual lumen catheters are described herein, but other multi-lumen catheters and tubular indwelling medical devices can also benefit from the teachings herein.
The design of the catheter tube 12 as shown in
In
Definition of the catheter tube 12 in the manner shown in
For instance,
In addition to the catheter tubes described herein as part of catheter assemblies, the principles disclosed can be employed with other tubular medical devices as well.
Reference is now made to
In greater detail, the access port 112 includes a body that defines a reservoir 116 to which is access is provided via a needle-penetrable septum 114 covering an opening to the reservoir. A stem 118 provides an outlet to the reservoir 116 and is configured to operably connect with the catheter tube 12 via a locking component 120. In one embodiment, the locking component 120 includes a Cath-Lock-type catheter locking component available from Bard Access Systems, Salt Lake City, Utah. In the present embodiment, the access port 112 (and the catheter tube 12) is configured for power injection of fluids therethrough, where the fluid flow rate is about 5 cc or more per second. In other embodiments, the access port and/or catheter tube need not be power injectable.
As shown in
Note that an inner diameter of the stem 118 of the access port 112 in the present embodiment is larger relative to other access ports of similar size so as to match the relatively large cross sectional area of the lumen 14 in the proximal taper region 24 of the catheter tube 12 when the stem and catheter tube are operably attached in a fluid-tight configuration. So configured, a relatively higher fluid flow rate through the stem 118 and catheter tube 12 is possible. As seen in
Similarly, the distal portion 30 includes the distal taper region 34, disposed at the proximal end of the distal portion adjacent to the distal end of the proximal portion 20, which provides a transition in cross sectional area of the lumen 14 from a predetermined cross-sectional lumen area proximal to the distal taper region 34 to a relatively larger cross-sectional lumen area distal to the distal taper region and extending to the catheter tube distal end 12B, as shown in
The particular function and aspects of the catheter tube 12 of
Reference is now also made to
As shown, the catheter tube 12 extends from the access port 112 and enters a vessel of the patient vasculature 132, such as a basilic vein 134 as depicted in
The catheter tube 12 further extends within the patient vasculature 132 such that the distal portion 30 thereof is disposed within a relatively large vein, such as a subclavian vein 138 in the present embodiment. The distal end 12B of the catheter tube 12 terminates at a desired location, such as proximate a superior vena cava (“SVC”) 142 of the heart 140 in the present embodiment, as shown in
In light of the above, it is seen that the relatively small proximal portion 20 of the catheter tube 12 is disposed within the relatively small basilic and axillary veins 134, 136, while the relatively larger distal portion 30 of the catheter tube is disposed within the relatively larger subclavian vein 138. As has been described further above in connection with previous embodiments, this provides several benefits. For one, it helps prevent undesired catheter tube-caused occlusion of the vein by matching the cross-sectional size of the portion of the catheter tube 12 with a corresponding relative cross-sectional size of the vein in which the catheter tube portion is disposed. Also, it assists in reducing the risk of thrombus and intimal damage within the vein. Further, the relatively smaller size of the catheter proximal portion 20 enables it to bend more easily during insertion into the patient's vasculature along a potentially tortuous path, resulting in less trauma and damage to the vessel.
Additionally, the relatively larger size of the distal portion 30 of the catheter tube 12 helps to provide stability to the distal end 12B of the catheter tube when fluids are power injected therethrough, thus helping to prevent whipping of the catheter tube distal end against vessel walls. Because of the relatively larger sizes of the lumen(s) 14 in the proximal taper region 24 and the distal portion 30, fluid flow resistance through the catheter tube 12 is reduced, which is beneficial especially during power injection of contrast media through the catheter tube. In one embodiment, power injection through the catheter tube 12 can exceed typical rates of about 5 cc/second given the relative general increase in catheter tube lumen size, all while preserving a relatively small size for the portion of the catheter tube that resides within relatively small veins, as shown in
Embodiments of the invention may be embodied in other specific forms without departing from the spirit of the present disclosure. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the embodiments is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application is a continuation of U.S. patent application Ser. No. 16/362,531, filed Mar. 22, 2019, now U.S. Pat. No. 10,905,850, which is a continuation of U.S. patent application Ser. No. 15/002,335, filed Jan. 20, 2016, now U.S. Pat. No. 10,238,833, which is a continuation-in-part of U.S. patent application Ser. No. 13/209,270, filed Aug. 12, 2011, now U.S. Pat. No. 9,913,960, which claims the benefit of U.S. Provisional Patent Application No. 61/373,000, filed Aug. 12, 2010, each of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3042044 | Sheridan | Jul 1962 | A |
3400714 | Sheridan | Sep 1968 | A |
3687142 | Leibinzohn | Aug 1972 | A |
4345602 | Yoshimura et al. | Aug 1982 | A |
4547193 | Rydell | Oct 1985 | A |
4563180 | Jervis et al. | Jan 1986 | A |
4735620 | Ruiz | Apr 1988 | A |
4769016 | Labianca | Sep 1988 | A |
4846814 | Ruiz | Jul 1989 | A |
4871356 | Haindl et al. | Oct 1989 | A |
4961731 | Bodicky et al. | Oct 1990 | A |
4961809 | Martin | Oct 1990 | A |
5041083 | Tsuchida et al. | Aug 1991 | A |
5085635 | Cragg | Feb 1992 | A |
5127917 | Niederhauser et al. | Jul 1992 | A |
5163431 | Griep | Nov 1992 | A |
5178803 | Tsuchida et al. | Jan 1993 | A |
5180364 | Ginsburg | Jan 1993 | A |
5201723 | Quinn | Apr 1993 | A |
5234425 | Fogarty et al. | Aug 1993 | A |
5292305 | Boudewijn et al. | Mar 1994 | A |
5316706 | Muni et al. | May 1994 | A |
5395353 | Scribner | Mar 1995 | A |
5399168 | Wadsworth, Jr. et al. | Mar 1995 | A |
5509900 | Kirkman | Apr 1996 | A |
5531717 | Roberto et al. | Jul 1996 | A |
5533985 | Wang | Jul 1996 | A |
5571093 | Cruz et al. | Nov 1996 | A |
5578006 | Schon | Nov 1996 | A |
5616137 | Lindsay | Apr 1997 | A |
5643228 | Schucart et al. | Jul 1997 | A |
5707385 | Williams | Jan 1998 | A |
5735832 | Karlsson | Apr 1998 | A |
5807349 | Person et al. | Sep 1998 | A |
5830196 | Hicks | Nov 1998 | A |
5843017 | Yoon | Dec 1998 | A |
5857464 | Desai | Jan 1999 | A |
5902282 | Balbierz | May 1999 | A |
5931831 | Linder | Aug 1999 | A |
5938635 | Kuhle | Aug 1999 | A |
5961536 | Mickley et al. | Oct 1999 | A |
5976120 | Chow et al. | Nov 1999 | A |
5989206 | Prosl et al. | Nov 1999 | A |
6010494 | Schafer et al. | Jan 2000 | A |
6045547 | Ren et al. | Apr 2000 | A |
6052612 | Desai | Apr 2000 | A |
6059748 | Teirstein et al. | May 2000 | A |
6059760 | Sandmore et al. | May 2000 | A |
6074379 | Prichard | Jun 2000 | A |
6090072 | Kratoska et al. | Jul 2000 | A |
6096022 | Laymon et al. | Aug 2000 | A |
6129700 | Fitz | Oct 2000 | A |
6132405 | Nilsson et al. | Oct 2000 | A |
6192568 | Kafrawy et al. | Feb 2001 | B1 |
6203532 | Wright | Mar 2001 | B1 |
6217565 | Cohen | Apr 2001 | B1 |
6280423 | Davey et al. | Aug 2001 | B1 |
6280434 | Kinoshita et al. | Aug 2001 | B1 |
6293958 | Berry et al. | Sep 2001 | B1 |
6450987 | Kramer | Sep 2002 | B1 |
6482211 | Choi | Nov 2002 | B1 |
6524299 | Tran et al. | Feb 2003 | B1 |
6533750 | Sutton et al. | Mar 2003 | B2 |
6533763 | Schneiter | Mar 2003 | B1 |
6579306 | Voelker et al. | Jun 2003 | B1 |
6579484 | Tiernan et al. | Jun 2003 | B1 |
6595966 | Davey et al. | Jul 2003 | B2 |
6620118 | Prosl et al. | Sep 2003 | B1 |
6626859 | von Segesser | Sep 2003 | B2 |
6638242 | Wilson et al. | Oct 2003 | B2 |
6638266 | Wilson et al. | Oct 2003 | B2 |
6651477 | Humphries et al. | Nov 2003 | B2 |
6663614 | Carter | Dec 2003 | B1 |
6669679 | Savage et al. | Dec 2003 | B1 |
6858024 | Berg et al. | Feb 2005 | B1 |
6866655 | Hackett | Mar 2005 | B2 |
6872198 | Wilson et al. | Mar 2005 | B1 |
6921396 | Wilson et al. | Jul 2005 | B1 |
6984219 | Ashby et al. | Jan 2006 | B2 |
7025751 | Silva et al. | Apr 2006 | B2 |
7037295 | Tiernan et al. | May 2006 | B2 |
7112191 | Daga | Sep 2006 | B2 |
7128734 | Wilson et al. | Oct 2006 | B1 |
7137963 | Nita et al. | Nov 2006 | B2 |
7300430 | Wilson et al. | Nov 2007 | B2 |
7381204 | Wilson et al. | Jun 2008 | B2 |
7393339 | Zawacki et al. | Jul 2008 | B2 |
7410602 | Davey et al. | Aug 2008 | B2 |
7566316 | McGuckin, Jr. et al. | Jul 2009 | B2 |
7566342 | Parker et al. | Jul 2009 | B2 |
7582051 | Khairkhahan et al. | Sep 2009 | B2 |
7682353 | Tanghoj et al. | Mar 2010 | B2 |
7686800 | Savage et al. | Mar 2010 | B2 |
7722567 | Tal | May 2010 | B2 |
7749185 | Wilson et al. | Jul 2010 | B2 |
7799046 | White et al. | Sep 2010 | B2 |
7833214 | Wilson et al. | Nov 2010 | B2 |
7846134 | Nadolski et al. | Dec 2010 | B1 |
7867271 | Geiser et al. | Jan 2011 | B2 |
7871398 | Chesnin et al. | Jan 2011 | B2 |
7955293 | Nita et al. | Jun 2011 | B2 |
7985213 | Parker | Jul 2011 | B2 |
8034072 | Nguyen et al. | Oct 2011 | B2 |
8603067 | Lareau et al. | Dec 2013 | B2 |
9913960 | Blanchard et al. | Mar 2018 | B2 |
10238833 | Christian et al. | Mar 2019 | B2 |
20010001117 | Chow | May 2001 | A1 |
20010018576 | Quinn | Aug 2001 | A1 |
20010051786 | Davey et al. | Dec 2001 | A1 |
20020072706 | Hiblar et al. | Jun 2002 | A1 |
20020099326 | Wilson et al. | Jul 2002 | A1 |
20030018322 | Tanghoj et al. | Jan 2003 | A1 |
20030036698 | Kohler et al. | Feb 2003 | A1 |
20030153873 | Luther et al. | Aug 2003 | A1 |
20030236545 | Gilson | Dec 2003 | A1 |
20040073122 | Stofer | Apr 2004 | A1 |
20040073171 | Rogers et al. | Apr 2004 | A1 |
20040097905 | Savage et al. | May 2004 | A1 |
20040171997 | Wilson et al. | Sep 2004 | A1 |
20040193139 | Armstrong et al. | Sep 2004 | A1 |
20040199192 | Akahoshi | Oct 2004 | A1 |
20040249338 | DeCant et al. | Dec 2004 | A1 |
20050027262 | Appling et al. | Feb 2005 | A1 |
20050038411 | Okada | Feb 2005 | A1 |
20050043649 | Urie | Feb 2005 | A1 |
20050080406 | Malecki et al. | Apr 2005 | A1 |
20050085778 | Parks | Apr 2005 | A1 |
20050090780 | Stone | Apr 2005 | A1 |
20050124969 | Fitzgerald | Jun 2005 | A1 |
20050187535 | Wilson et al. | Aug 2005 | A1 |
20050209581 | Butts et al. | Sep 2005 | A1 |
20060004316 | Difiore et al. | Jan 2006 | A1 |
20060041244 | Hohmann et al. | Feb 2006 | A1 |
20060041269 | Horrigan | Feb 2006 | A1 |
20060281965 | Khairkhahan et al. | Dec 2006 | A1 |
20070043390 | Neilan | Feb 2007 | A1 |
20070060880 | Gregorich et al. | Mar 2007 | A1 |
20070073271 | Brucker et al. | Mar 2007 | A1 |
20070219466 | Tremulis et al. | Sep 2007 | A1 |
20070225661 | Ash et al. | Sep 2007 | A1 |
20080172008 | Root et al. | Jul 2008 | A1 |
20090012481 | Davey et al. | Jan 2009 | A1 |
20090093795 | Koeper | Apr 2009 | A1 |
20090131882 | Naimark et al. | May 2009 | A1 |
20090143748 | Mickley et al. | Jun 2009 | A1 |
20090221961 | Tal et al. | Sep 2009 | A1 |
20090247987 | Chevalier, Jr. et al. | Oct 2009 | A1 |
20090254116 | Rosenschein et al. | Oct 2009 | A1 |
20090292272 | McKinnon | Nov 2009 | A1 |
20090306606 | Lancette et al. | Dec 2009 | A1 |
20090312687 | DeFonzo et al. | Dec 2009 | A1 |
20110034875 | Chesnin et al. | Feb 2011 | A1 |
20110202002 | Gordon et al. | Aug 2011 | A1 |
20110213309 | Young et al. | Sep 2011 | A1 |
20110213318 | Schertiger | Sep 2011 | A1 |
20120016311 | Altman et al. | Jan 2012 | A1 |
20120041419 | Blanchard et al. | Feb 2012 | A1 |
20120232496 | Lareau et al. | Sep 2012 | A1 |
20120245563 | Lareau et al. | Sep 2012 | A1 |
20150289781 | Grunwald et al. | Oct 2015 | A1 |
20190217056 | Christian et al. | Jul 2019 | A1 |
Number | Date | Country |
---|---|---|
103068435 | Apr 2013 | CN |
2603275 | Jun 2013 | EP |
1996006653 | Mar 1996 | WO |
9639217 | Dec 1996 | WO |
2004030577 | Apr 2004 | WO |
2009131583 | Oct 2009 | WO |
2009142904 | Nov 2009 | WO |
2010020971 | Feb 2010 | WO |
2010039456 | Apr 2010 | WO |
2010054666 | May 2010 | WO |
2012021844 | Feb 2012 | WO |
2017127074 | Jul 2017 | WO |
Entry |
---|
CN 201180039622.X filed Feb. 16, 2013 First Office Action dated Aug. 4, 2014. |
CN 201180039622.X filed Feb. 16, 2013 second Office Action dated May 15, 2015. |
CN 201180039622.X filed Feb. 16, 2013 Third Office Action dated Oct. 10, 2015. |
EP 11817136.2 filed Jan. 24, 2014 Extended European Search Report, dated Sep. 19, 2017. |
EP 16886714.1 filed Aug. 20, 2018 Extended European Search Report dated Aug. 30, 2019. |
KR 10-2013-7006208 filed Mar. 11, 2013 Office Action dated Jan. 9, 2018. |
KR 10-2013-7006208 filed Mar. 11, 2013 Office Action dated Jul. 30, 2018. |
MX/a/2013/000715 filed Jan. 17, 2013 First Office Action dated Feb. 12, 2015. |
MX/a/2013/000715 filed Jan. 17, 2013 Second Office Action dated Jun. 4, 2015. |
MX/a/2013/000715 filed Jan. 17, 2013 Third Office Action dated Oct. 12, 2015. |
PCT/US2011/047656 filed Aug. 12, 2011 International Search Report and Written Opinion dated Mar. 9, 2012. |
PCT/US2016/014190 filed Jan. 20, 2016 International Search Report and Written Opinion dated Mar. 29, 2016. |
Silverstein, Beth et al., Abstract, “Assessing the Role of the Biomaterial Aquavene in Patient Reactions to Landmark Midline Catheters,” Regulatory Toxicology and Pharmacology, vol. 25, Issue 1, pp. 60-67, Feb. 1997. |
U.S. Appl. No. 13/209,270, filed Aug. 12, 2011 Final Office Action dated Jul. 10, 2014. |
U.S. Appl. No. 13/209,270, filed Aug. 12, 2011 Final Office Action dated May 27, 2015. |
U.S. Appl. No. 13/209,270, filed Aug. 12, 2011 Non-Final Office Action dated Feb. 26, 2014. |
U.S. Appl. No. 13/209,270, filed Aug. 12, 2011 Non-Final Office Action dated Jan. 14, 2015. |
U.S. Appl. No. 13/209,270, filed Aug. 12, 2011 Non-Final Office Action dated Oct. 25, 2013. |
U.S. Appl. No. 13/209,270, filed Aug. 12, 2011 Notice of Allowance dated Nov. 15, 2017. |
U.S. Appl. No. 13/474,004, filed May 17, 2012 Final Office Action dated May 8, 2013. |
U.S. Appl. No. 13/474,004, filed May 17, 2012 Final Office Action dated Oct. 19, 2012. |
U.S. Appl. No. 13/474,004, filed May 17, 2012 Non-Final Office Action dated Dec. 27, 2012. |
U.S. Appl. No. 13/474,004, filed May 17, 2012 Non-Final Office Action dated Jul. 13, 2012. |
U.S. Appl. No. 13/474,004, filed May 17, 2012 Notice of Allowance dated Sep. 12, 2013. |
U.S. Appl. No. 15/002,335, filed Jan. 20, 2016 Non-Final Office Action dated May 25, 2018. |
U.S. Appl. No. 15/002,335, filed Jan. 20, 2016 Restriction Requirement dated May 2, 2018. |
U.S. Appl. No. 16/362,531, filed Mar. 22, 2019 Notice of Allowance dated Oct. 30, 2020. |
EP 22195818.4 filed Extended European Search Report dated Nov. 30, 2022. |
Number | Date | Country | |
---|---|---|---|
20210146094 A1 | May 2021 | US |
Number | Date | Country | |
---|---|---|---|
61373000 | Aug 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16362531 | Mar 2019 | US |
Child | 17161414 | US | |
Parent | 15002335 | Jan 2016 | US |
Child | 16362531 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13209270 | Aug 2011 | US |
Child | 15002335 | US |